Skin & hair

When a Photo Isn't Enough for a Dermatologist

Save

A photo can resolve a flaring rash or a medication check without anyone leaving the house. It cannot resolve a spot that needs tissue under a microscope to know what it is. This lays out exactly where that line sits, and what to do when a virtual visit turns out to be the wrong tool.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What Teledermatology Handles Well

Teledermatology handles a wide slice of dermatology well: acne progress checks, eczema flares, psoriasis medication follow-ups, a rash with a classic and recognizable pattern, or a prescription renewal for a condition already diagnosed in person. Both live-interactive video visits and store-and-forward photo review are built for exactly this kind of visual, low-ambiguity problem, and the American Academy of Dermatology maintains standards for image quality and platform security specifically so those visits can be read reliably 1.

For all of that, a virtual visit works best as a tool for something already understood rather than something new and ambiguous. A patient who has had eczema for years and knows what a flare looks like is a good fit for a photo check; a new spot nobody has seen before is a different situation entirely, and treating the two the same is where teledermatology's limits start to show.

The Three Things a Photo Cannot Do

Three things a photo cannot do define where teledermatology stops. It cannot biopsy: taking a tissue sample for a pathologist requires a clinician physically present with a scalpel or punch tool, and biopsy technique itself changes depending on what's suspected — a shave or punch sample for a routine lesion, a narrower full-thickness sample when melanoma is even a possibility, because how the tissue is taken affects how accurately it can later be staged 2. It cannot palpate: texture, firmness, and depth under the skin tell a dermatologist things a flat image never will. And it cannot perform a true full-body exam, which by definition finds things the patient didn't already know to photograph.

A Changing or Worrying Mole Needs Eyes and Hands, Not a Screen

Any mole or patch that is changing, bleeding, growing, or simply bothering the person looking at it belongs in front of a dermatologist in person, and this is not a call to make from a written description or a single photo. Melanoma is far less common than other skin cancers but disproportionately dangerous, and outcomes differ sharply by how early it's caught 3 — so the response to a worrying spot is the same regardless of how confident anyone feels reading it from a screen: photograph it now for a dated record, watch it, and get it in front of a dermatologist rather than waiting to see if a photo consult can settle it.

Store-and-Forward vs. Live Video — Neither Replaces an Exam Room

Store-and-forward and live-interactive teledermatology are not the same tool, and the difference matters for what each can catch. Store-and-forward — a patient submits photos and a history, and a dermatologist reviews asynchronously — depends entirely on image quality and the patient's ability to photograph the right area at the right angle and lighting. Live-interactive video adds real-time questioning and the ability to ask for another angle on the spot, but neither replaces the resolution and lighting control of an exam room, which is part of why AAD standards exist specifically to keep both formats as reliable as the format allows 1.

Neither format lets a clinician redirect a camera the way they'd reposition their own eyes and hands during an in-person exam. A patient photographing their own back, in particular, is working with a mirror and an awkward angle at exactly the spot statistically likely to be missed on self-exam, which is one reason a periodic in-person check still has a role even for people who use teledermatology regularly for everything else.

When a Virtual Visit Refers You Out, Take the Referral

A teledermatology visit that doesn't resolve the question is doing its job correctly, not failing — escalation to an in-person exam is a built-in outcome, not a fallback. Most reputable platforms include a pathway to refer a patient to in-person care when a lesion looks atypical, when a rash doesn't fit a clear pattern, or when the clinician simply can't get enough information from images alone; taking that referral seriously, rather than shopping for a second telederm opinion that says what the first one didn't, is the safer move.

It helps to ask directly, at the end of a virtual visit, whether the clinician would want to see the spot in person if it were on their own skin. That question tends to surface hedging that a routine "keep an eye on it" summary can gloss over, and it puts the escalation decision explicitly on the table instead of leaving it implied.

Diagnostic, Not Screening — Why That Changes Coverage

A concern raised during a virtual visit is a diagnostic question, not a screening one, and that distinction affects both urgency and insurance coverage. The national preventive-services task force found the evidence insufficient to universally recommend routine whole-body skin exams in people without symptoms, but that finding is explicitly about screening asymptomatic patients — it says nothing about evaluating a specific lesion a patient or clinician is already concerned about 4, which is a diagnostic exam and is treated differently by most plans.

Confirming that difference before booking the in-person follow-up is worth the phone call: a diagnostic visit prompted by a specific spot is generally covered more predictably than a routine full-body screening exam, and some plans require the referral to be documented as diagnostic rather than preventive to process it that way.

Closing the Gap When In-Person Means a Wait

Getting an in-person appointment can mean a real wait, because dermatologists are unevenly distributed and concentrated in metropolitan areas, leaving many rural counties with few or none within a reasonable drive 5. Asking a telederm clinician to flag the referral as urgent, calling practices directly for a cancellation-list spot, or asking a primary care doctor for a faster route in are all reasonable ways to close that gap — and worth doing before a visit, since knowing how to prepare for a dermatology appointment in advance keeps the in-person visit itself short and focused.

Bringing the original teledermatology photos and notes to the in-person visit also saves time, since it gives the in-person dermatologist a dated starting point for comparison rather than starting the observation history over from zero.

Common questions

A photo can raise or lower suspicion, but a diagnosis requires a biopsy — tissue examined under a microscope by a pathologist. No teledermatology visit, however good the image, substitutes for that step when a lesion is genuinely suspicious; the photo consult's job in that scenario is to get the patient into an in-person exam quickly, not to render a verdict.

They serve different purposes rather than one being simply better. Store-and-forward depends heavily on photo quality and the areas the patient chose to capture; live video allows real-time follow-up questions and different angles on request. Neither includes touch, and both are best suited to visual, previously-characterized conditions rather than a new or changing lesion.

Persistent worry about a specific spot is itself a reasonable reason to ask for an in-person evaluation, regardless of what a virtual read suggested. Photographing the spot with a ruler or coin for scale, noting the date, and requesting an in-person referral directly are all reasonable next steps; a second telederm opinion is not a substitute for hands-on examination when a spot won't stop bothering someone.

Often yes, and it depends on the plan and whether the visit is coded as screening or diagnostic. A visit prompted by a specific concerning spot is typically diagnostic rather than screening, which is usually covered more consistently than a routine screening exam in someone without symptoms, but confirming with the plan directly before booking avoids a billing surprise.

There's no universal number of days that applies to every lesion, since urgency depends on what the referring clinician saw, but a referral for a suspicious or changing mole is not something to sit on. Calling to ask about a cancellation list, requesting the earliest available slot, and mentioning the referral reason directly when booking all tend to move the timeline up.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When a Virtual Visit Isn't Enough

  • a mole or spot that is changing in size, shape, or color over weeks
  • a sore or spot that bleeds, crusts, or won't heal
  • a new dark streak under a nail, or a new spot on skin that rarely sees the sun
  • any lesion a teledermatology clinician flags as atypical, even if described as not urgent

This article explains the limits of virtual dermatology visits and is not medical advice; it does not evaluate or diagnose any specific skin change.

References

  1. 1.American Academy of Dermatology (2024). Teledermatology Standards. American Academy of Dermatology. linkAAD standards for teledermatology practice, including image-quality and platform-security expectations for both live-interactive and store-and-forward formats.
  2. 2.American Family Physician (2011). Shave and Punch Biopsy for Skin Lesions. American Family Physician. linkBiopsy technique varies by what's suspected, and narrow full-thickness sampling is preferred over superficial sampling when melanoma is a possibility, to preserve staging accuracy — a procedure that requires an in-person clinician.
  3. 3.National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program (2025). Cancer Stat Facts: Melanoma of the Skin. NIH / National Cancer Institute (SEER). linkGeneral epidemiologic support that melanoma is comparatively uncommon among skin cancers but carries disproportionate mortality risk, and that survival differs by stage at diagnosis.
  4. 4.US Preventive Services Task Force (2023). Skin Cancer: Screening. US Preventive Services Task Force. linkUSPSTF's insufficient-evidence finding applies to routine whole-body screening in asymptomatic adults, not to diagnostic evaluation of a specific concerning lesion.
  5. 5.Feng H, Berk-Krauss J, Feng PW, Stein JA (2018). Comparison of Dermatologist Density Between Urban and Rural Counties in the United States. JAMA Dermatology. PMID 28296988Dermatologists are concentrated in metropolitan areas, creating access gaps and longer waits for in-person exams in many rural counties.

5 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy